DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Invicta Diagnostic Limited — Outcome of Board Meeting

NSE 54 min ago·18 Sept 2026, 8:07 am

Invicta Diagnostic

Invicta Diagnostic Limited has informed the stock exchange that its Board of Directors has approved the business outlook and forward-looking guidance. This guidance is set to be presented by the Chairman & Managing Director and the Chief Financial Officer at the company's 3rd Annual General Meeting (AGM) on September 19, 2026.

For investors, this update is significant as it provides a preview of the company's strategic direction and financial expectations for the coming period. It offers a crucial opportunity to understand management's confidence in future growth and operational plans before the formal AGM proceedings.

Investors should watch for the specific details regarding revenue targets, profitability, and expansion strategies outlined by the company's leadership. This information will be key in assessing the company's trajectory and making informed investment decisions.